Food and Chemical Toxicology – 2024

Food safety assessment and 28-day toxicity study of the synbiotic Medical Food consortium SBD121.
Easson DD, Murphy VA, Ballok AE, Soto-Giron MJ, Miller KJ, Charbonneau MR, Schott EM, Greene T, Rodricks J, Toledo GV

Gut Microbes – 2023

The edible plant microbiome: evidence for the occurrence of fruit and vegetable bacteria in the human gut
Wicaksono W, Cernava T, Wassermann B, Abdelfattah A, Soto-Giron M, Toledo G, Virtanen S, Knip M, Hyöty H, Berg G

Clinical trial: SBD121, a Synbiotic Medical Food for RA Management – 2023

The aim of this randomised, double-blind, placebo controlled clinical food trial is to determine if the medical food SBD121 Synbiotic (prebiotic and probiotic) will aid in the dietary management of symptoms of early rheumatoid arthritis (RA).

Journal of Microbiology & Experimentation – 2023

Randomized clinical trial to test the safety and tolerability of SBD111, an optimized synbiotic medical food combination designed for the dietary management of the metabolic processes underlying osteopenia and osteoporosis.
Sahni S, Schott E, Caroll D, Soto-Giron M, Corbett S, Toledo G, Kiel D.

Nature Biopharma Dealmakers – 2022

Managing inflammatory diseases and aging with edible plant microbes

Clinical trial: Food Trial Evaluating the Efficacy of SBD111 Versus Placebo for the Clinical Dietary Management of the Metabolic Processes of Osteopenia – 2022

The aim of the trial is to determine if the SYNBIOTIC (prebiotic and probiotic), provided twice daily (capsule) will help support skeletal health in otherwise healthy postmenopausal women in the early years postmenopause (1-6 years post last menstruation) over a 12-month period.